UA101057C2 - Pyrimidine derivatives as kinase inhibitors - Google Patents
Pyrimidine derivatives as kinase inhibitorsInfo
- Publication number
- UA101057C2 UA101057C2 UAA201104068A UAA201104068A UA101057C2 UA 101057 C2 UA101057 C2 UA 101057C2 UA A201104068 A UAA201104068 A UA A201104068A UA A201104068 A UAA201104068 A UA A201104068A UA 101057 C2 UA101057 C2 UA 101057C2
- Authority
- UA
- Ukraine
- Prior art keywords
- pyrimidine derivatives
- kinase inhibitors
- analplastic
- igf
- alk
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Abstract
Даний винахід забезпечує нові похідні піримідину, їх фармацевтичні композиції та застосування таких сполук.Наприклад, похідні піримідину даного винаходу можуть бути використані для лікування, полегшення симптомів або профілактики стану, який реагує на інгібування інсуліноподібного фактора росту (IGF-1R) або кінази анапластичної лімфоми (ALK).
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US7558308P | 2008-06-25 | 2008-06-25 | |
PCT/US2009/048428 WO2010002655A2 (en) | 2008-06-25 | 2009-06-24 | Compounds and compositions as kinase inhibitors |
Publications (1)
Publication Number | Publication Date |
---|---|
UA101057C2 true UA101057C2 (en) | 2013-02-25 |
Family
ID=41076758
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UAA201104068A UA101057C2 (en) | 2008-06-25 | 2009-06-24 | Pyrimidine derivatives as kinase inhibitors |
Country Status (11)
Country | Link |
---|---|
EP (1) | EP2331526A2 (uk) |
JP (1) | JP2011526291A (uk) |
KR (1) | KR20110020940A (uk) |
CN (1) | CN102203083A (uk) |
AU (1) | AU2009262198B2 (uk) |
BR (1) | BRPI0914545A2 (uk) |
CA (1) | CA2729546A1 (uk) |
EA (1) | EA201100078A1 (uk) |
MX (1) | MX2010014568A (uk) |
UA (1) | UA101057C2 (uk) |
WO (1) | WO2009158431A2 (uk) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8729265B2 (en) | 2009-08-14 | 2014-05-20 | Boehringer Ingelheim International Gmbh | Regioselective preparation of 2-amino-5-trifluoromethylpyrimidine derivatives |
US8933227B2 (en) | 2009-08-14 | 2015-01-13 | Boehringer Ingelheim International Gmbh | Selective synthesis of functionalized pyrimidines |
WO2011112666A1 (en) | 2010-03-09 | 2011-09-15 | OSI Pharmaceuticals, LLC | Combination anti-cancer therapy |
US8987307B2 (en) | 2011-03-03 | 2015-03-24 | Hoffmann-La Roche Inc. | 3-amino-pyridines as GPBAR1 agonists |
CA2850594C (en) * | 2011-11-29 | 2020-03-10 | F. Hoffmann-La Roche Ag | Aminopyrimidine derivatives as lrrk2 modulators |
US9206166B2 (en) | 2012-11-06 | 2015-12-08 | SHANGHAI iNSTITUTE OF MATERIA MEDICA ACADEMY OF SCIENCES | Certain protein kinase inhibitors |
PT2970205T (pt) * | 2013-03-14 | 2019-08-26 | Tolero Pharmaceuticals Inc | Inibidores da jak2 e da alk2 e métodos para a sua utilização |
EP3150592B1 (en) * | 2014-05-30 | 2023-08-30 | Shanghai Emerald Wellcares Pharmaceutical Co., LTD | Alk kinase inhibitor, and preparation method and use thereof |
US10377743B2 (en) * | 2016-10-07 | 2019-08-13 | Araxes Pharma Llc | Inhibitors of RAS and methods of use thereof |
CN107488148A (zh) * | 2017-06-26 | 2017-12-19 | 安徽省黄淮兽药有限公司 | 一种苯丙酰胺类杀虫剂及其制备方法 |
CN112020500A (zh) | 2017-12-22 | 2020-12-01 | 拉文纳制药公司 | 作为磷脂酰肌醇磷酸激酶抑制剂的氨基吡啶衍生物 |
TW202045008A (zh) * | 2019-02-01 | 2020-12-16 | 印度商皮埃企業有限公司 | 4-取代的異噁唑/異噁唑啉(雜)芳基脒化合物、及其製備與用途 |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0004890D0 (en) * | 2000-03-01 | 2000-04-19 | Astrazeneca Uk Ltd | Chemical compounds |
WO2003026665A1 (en) * | 2001-09-26 | 2003-04-03 | Bayer Pharmaceuticals Corporation | 2-phenylamino-4-(5-pyrazolylamino)-pyrimidine derivatives as kinase inhibitors, in particular, src kinase inhibitors |
KR101201603B1 (ko) * | 2003-07-30 | 2012-11-14 | 리겔 파마슈티칼스, 인크. | 자가면역 질환의 치료 또는 예방에 사용하기 위한2,4-피리미딘디아민 화합물 |
EP1663242B1 (en) * | 2003-08-07 | 2011-04-27 | Rigel Pharmaceuticals, Inc. | 2,4-pyrimidinediamine compounds and uses as anti-proliferative agents |
GB0321710D0 (en) * | 2003-09-16 | 2003-10-15 | Novartis Ag | Organic compounds |
JP2007505858A (ja) * | 2003-09-18 | 2007-03-15 | ノバルティス アクチエンゲゼルシャフト | 増殖性障害の処置に有用な2,4−ジ(フェニルアミノ)ピリミジン |
JP5208516B2 (ja) * | 2004-12-30 | 2013-06-12 | エグゼリクシス, インコーポレイテッド | キナーゼモジュレーターとしてのピリミジン誘導体および使用方法 |
JP2008540436A (ja) * | 2005-05-03 | 2008-11-20 | ライジェル ファーマシューティカルズ, インコーポレイテッド | Jakキナーゼインヒビターおよびそれらの使用 |
US8222256B2 (en) * | 2006-07-05 | 2012-07-17 | Exelixis, Inc. | Methods of using IGFIR and ABL kinase modulators |
BRPI0722384A2 (pt) * | 2006-12-08 | 2012-06-12 | Irm Llc | compostos inibidores de proteÍna quinase, composiÇÕes contendo os mesmos bem como seus usos |
EP2091918B1 (en) * | 2006-12-08 | 2014-08-27 | Irm Llc | Compounds and compositions as protein kinase inhibitors |
WO2009017838A2 (en) * | 2007-08-01 | 2009-02-05 | Exelixis, Inc. | Combinations of jak-2 inhibitors and other agents |
CA2713716A1 (en) * | 2008-02-22 | 2009-08-27 | F. Hoffmann-La Roche Ag | Modulators for amyloid beta |
-
2009
- 2009-06-24 UA UAA201104068A patent/UA101057C2/ru unknown
- 2009-06-24 EP EP09770964A patent/EP2331526A2/en not_active Withdrawn
- 2009-06-24 BR BRPI0914545A patent/BRPI0914545A2/pt not_active IP Right Cessation
- 2009-06-24 WO PCT/US2009/048509 patent/WO2009158431A2/en active Application Filing
- 2009-06-24 AU AU2009262198A patent/AU2009262198B2/en not_active Expired - Fee Related
- 2009-06-24 JP JP2011516619A patent/JP2011526291A/ja not_active Ceased
- 2009-06-24 CA CA2729546A patent/CA2729546A1/en not_active Abandoned
- 2009-06-24 KR KR1020117001749A patent/KR20110020940A/ko not_active Application Discontinuation
- 2009-06-24 EA EA201100078A patent/EA201100078A1/ru unknown
- 2009-06-24 MX MX2010014568A patent/MX2010014568A/es not_active Application Discontinuation
- 2009-06-24 CN CN200980129584XA patent/CN102203083A/zh active Pending
Also Published As
Publication number | Publication date |
---|---|
EA201100078A1 (ru) | 2011-08-30 |
BRPI0914545A2 (pt) | 2017-05-23 |
JP2011526291A (ja) | 2011-10-06 |
WO2009158431A3 (en) | 2010-03-11 |
EP2331526A2 (en) | 2011-06-15 |
CA2729546A1 (en) | 2009-12-30 |
KR20110020940A (ko) | 2011-03-03 |
AU2009262198B2 (en) | 2012-09-27 |
WO2009158431A2 (en) | 2009-12-30 |
MX2010014568A (es) | 2011-03-29 |
CN102203083A (zh) | 2011-09-28 |
AU2009262198A1 (en) | 2009-12-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2010002655A3 (en) | Pyrimidine derivatives as kinase inhibitors | |
MX2010002336A (es) | Derivados de 2-bifenil-amino-4-amino-pirimidina como inhibidores de cinasa. | |
UA101057C2 (en) | Pyrimidine derivatives as kinase inhibitors | |
UA100846C2 (uk) | Сполуки та композиція як інгібітори протеїнкінази | |
TN2009000225A1 (en) | Compounds and compositions as protein kinase kinase inhibitors | |
MX2010010968A (es) | Compuestos y composiciones como inhibidores de cinasa de proteina. | |
WO2009126514A8 (en) | Compounds and compositions as kinase inhibitors | |
MX2012000711A (es) | Inhibidores de pirrolopirazina de cinasas. | |
MX2009000884A (es) | Derivados de piridizinona. | |
MY149512A (en) | Pyrazolylaminopyridine derivatives useful as kinase inhibitors | |
MX2012013197A (es) | Inhibidores de indazol de cinasa. | |
MX2012000709A (es) | Inhibidores de pirrolopiridina de cinasas. | |
MX2011013325A (es) | 2-(lh-pirazol-4-ilamino)-pirimidina como inhibidores de cinasa. | |
MX336726B (es) | Compuestos heterociclicos y su uso como inhibidores de la glucogeno sintasa quinasa-3. | |
AU2011276193A8 (en) | Bipyridyl derivatives useful for the treatment of kinase - induced diseases | |
MX2009004140A (es) | Compuestos heterociclicos y su uso como inhibidores de la glucogeno sintasa quinasa 3. | |
TN2011000207A1 (en) | Akt and p70 s6 kinase inhibitors | |
MX2011012632A (es) | Inhibidores de actividad de cinasa tipo pirimidina. | |
MX2011012629A (es) | Inhibidores de actividad de cinasa tipo pirimidina. | |
MX2011012631A (es) | Inhibidores de actividad de cinasa tipo pirimidina. | |
WO2009094560A3 (en) | Thienopyranones as kinase inhibitors | |
WO2010039668A3 (en) | Inhibitors of cyclin kinase inhibitor p21 | |
MX2010004604A (es) | Derivados de pirazol como inhibidores de 5-lo. | |
MX2009012079A (es) | Compuestos heterociclicos condensados como inhibidores de proteina cinasas. | |
MX2009003793A (es) | Inhibidores de cinasa. |